Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the efficacy and safety of HTMC0658 tablets for chronic rhinosinusitis without nasal polyps; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis Without Nasal Polyps

Drugs mentioned

• HTMC0658 tablets (HTMC0658)

Snippet

Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | Conditions: Chronic Sinusitis Without Nasal Polyps | Phase 2 | Status: RECRUITING